ANGIOTENSIN II RECEPTOR SIGNALING DOMAINS
血管紧张素 II 受体信号传导域
基本信息
- 批准号:6184982
- 负责人:
- 金额:$ 29.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-18 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:angiotensin II angiotensin receptor autoradiography biological signal transduction caveolas electron microscopy electroporation enzyme activity hormone regulation /control mechanism immunologic assay /test membrane activity membrane structure mitogen activated protein kinase phospholipase C phospholipase D protein tyrosine kinase receptor binding receptor expression tissue /cell culture vascular smooth muscle
项目摘要
DESCRIPTION: (Adapted from the application) Angiotensin II (angII) is
a pleiotropic hormone with an extraordinary repertoire of signaling
responses associated with activation of its receptors. The prototype
ang II receptor is the AT1AR of vascular smooth muscle (VSMC). AT1AR
activation in VSMC is associated with the sequential activation of
phospholipase Cs (PLC) and phospholipase D (PLD). The initial PLC
activation rapidly desensitizes and is followed immediately by PLD
protein coupled AT1AR also activates a variety of receptor tyrosine
kinase. The PIs propose that these various signals are organized by
being associated with specific temporal and spatial domains. The major
general object of this proposal is to understand the signaling
repertoire by providing insights into the coupling protein linking the
AT1AR to effector molecules and into the mechanisms controlling receptor
trafficking into signaling or recycling domains. Preliminary evidence
suggests that this domain is the caveola. A major underlying hypothesis
is that the receptor trafficking controls the pattern of signal
generation. An important recent accomplishment of the program is the
development and refinement of the technique of electroportation of
antibodies against specific signaling components into VSMC. This
approach, for example, has permitted assignment of a pivotal role for
the Gg subunit in transducing AT1AR signaling. The PIs have developed
a general model that guides development and testing of specific
mechanistic hypotheses concerning angII signaling events in VSMC. To
test the general model we propose the following specific aims: 1)
Define the specific membrane domains to which the activated AT1AR is
mobilized after activation; 2) Determine the role of caveolae as the
site of activation of the tonic component of the biphasic signaling
response; 3) Determine the mechanism of activation of tyrosine kinase
by the AT1AR in caveolae; 4) Examine the role of caveolae in oxidant-
sensitive AT1AR-mediated signal transduction; 5) Using the baculovirus
expression system and information from cell studies, determine which
components of the AT1AR signaling pathways physically interact. These
studies should provide new insights into the mechanisms by which ang II
fulfills its pivotal physiologic and pathophysiologic roles.
描述:(改编自应用)血管紧张素II (angII)是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert WAYNE ALEXANDER其他文献
Robert WAYNE ALEXANDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert WAYNE ALEXANDER', 18)}}的其他基金
相似海外基金
Exploratory Efficacy-Evaluation Study of Angiotensin Receptor-Neprilysin Inhibitor in patients with dialysis
血管紧张素受体脑啡肽酶抑制剂在透析患者中的探索性疗效评价研究
- 批准号:
21K16191 - 财政年份:2021
- 资助金额:
$ 29.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
慢性肾脏病的个体化血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂治疗
- 批准号:
10313873 - 财政年份:2021
- 资助金额:
$ 29.4万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10469311 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis - a Randomized Controlled Trial
血管紧张素受体阻滞剂对主动脉瓣狭窄的影响 - 一项随机对照试验
- 批准号:
433568 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Operating Grants
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10649490 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10210299 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10065083 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Mechanism of suppressive effects for atherosclerosis by Angiotensin Receptor-Neprilysin Inhibitor
血管紧张素受体脑啡肽酶抑制剂抑制动脉粥样硬化的机制
- 批准号:
19K17618 - 财政年份:2019
- 资助金额:
$ 29.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathophysiological significance of angiotensin receptor-binding protein in leucocytes and immune cells
白细胞和免疫细胞中血管紧张素受体结合蛋白的病理生理意义
- 批准号:
19K17575 - 财政年份:2019
- 资助金额:
$ 29.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
AgRP 神经元中血管紧张素受体 G 蛋白信号转换在心脏代谢控制中的作用
- 批准号:
10658260 - 财政年份:2017
- 资助金额:
$ 29.4万 - 项目类别:














{{item.name}}会员




